Didier Verhoeven

2.6k total citations · 1 hit paper
39 papers, 1.4k citations indexed

About

Didier Verhoeven is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Didier Verhoeven has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Genetics. Recurrent topics in Didier Verhoeven's work include Cancer Treatment and Pharmacology (9 papers), HER2/EGFR in Cancer Research (9 papers) and Advanced Breast Cancer Therapies (7 papers). Didier Verhoeven is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), HER2/EGFR in Cancer Research (9 papers) and Advanced Breast Cancer Therapies (7 papers). Didier Verhoeven collaborates with scholars based in Belgium, Italy and United States. Didier Verhoeven's co-authors include Guy Jérusalem, Kelly Pendergrass, Angelo Di Leo, Roberto Torres, Sally Garnett, Igor Bondarenko, Р. Ш. Хасанов, Luboš Petruželka, Miguel Martín and José Luiz Pedrini and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Didier Verhoeven

37 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer

2010 453 citations Angelo Di Leo, Guy Jérusalem et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Didier Verhoeven

Since Specialization

Citations

This map shows the geographic impact of Didier Verhoeven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Verhoeven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Verhoeven more than expected).

Fields of papers citing papers by Didier Verhoeven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Verhoeven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Verhoeven. The network helps show where Didier Verhoeven may publish in the future.

Co-authorship network of co-authors of Didier Verhoeven

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Verhoeven. A scholar is included among the top collaborators of Didier Verhoeven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Verhoeven. Didier Verhoeven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High-value breast cancer care within resource limitations 2024 ·The Oncologist ·Didier Verhoeven, (unknown), Claudia Allemani, Pankaj G. Roy, Luzia Travado, Nirmala Bhoo‐Pathy, (unknown), H. Junkermann, Seigo Nakamura, (unknown), F. Lee Tucker	3
2	Survival and Quality of care offered in Belgian hospitals with and without recognition for breast cancer 2023 ·Roos Leroy, Cindy De Gendt, Jolyce Bourgeois, (unknown), Isabelle Savoye, Geert Silversmit, Nancy Van Damme, Birgit Carly, Cécile Colpaert, P. Cusumano, Pieter De Visschere, (unknown), Joëlle Desreux, François P. Duhoux, (unknown), (unknown), D. H. Taylor, Liv Veldeman, Didier Verhoeven, Hans Wildiers	0
3	Borstkankerzorg in centra met en zonder erkenning voor borstkanker – Is er een verschil? - Synthese 2023 ·Ghent University Academic Bibliography (Ghent University) ·Roos Leroy, Cindy De Gendt, Jolyce Bourgeois, (unknown), Isabelle Savoye, Geert Silversmit, Nancy Van Damme, Birgit Carly, Cécile Colpaert, P. Cusumano, Pieter De Visschere, (unknown), Joëlle Desreux, François P. Duhoux, (unknown), (unknown), D. H. Taylor, Liv Veldeman, Didier Verhoeven, Hans Wildiers	1
4	Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium 2023 ·Breast Cancer Research and Treatment ·Mariana Brandão, Diogo Martins-Branco, Claudia De Angelis, Peter Vuylsteke, Richard D. Gelber, Nancy Van Damme, (unknown), Arlindo R. Ferreira, Matteo Lambertini, Francesca Poggio, Didier Verhoeven, (unknown), François P. Duhoux, Hans Wildiers, Carmela Caballero, Ahmad Awada, Martine Piccart, Kevin Punie, Evandro de Azambuja	4
5	Trends and variation in treatment of early breast cancer in European certified breast centres: an EUSOMA-based analysis 2023 ·European Journal of Cancer ·(unknown), Didier Verhoeven, Lorenza Marotti, Antonio Ponti, Mariano Tomatis, Isabel T. Rubio	3
6	Implementing and monitoring the right to health in breast cancer: selection of indicators using a Delphi process 2023 ·International Journal for Equity in Health ·Lisa Montel, Michel P. Coleman, Thérèse Murphy, Dina Balabanova, (unknown), Dabney P. Evans, (unknown), Didier Verhoeven, Claudia Allemani	0
7	New Frontiers for Fairer Breast Cancer Care in a Globalized World 2021 ·SHILAP Revista de lepidopterología ·Didier Verhoeven, Claudia Allemani, Cary S. Kaufman, Sabine Siesling, Manuela Joore, Étienne Brain, Maurício Magalhães Costa	4
8	Assessment of potential process quality indicators for systemic treatment of breast cancer in Belgium: a population-based study 2021 ·ESMO Open ·(unknown), Kevin Punie, E. Van Eycken, Evandro de Azambuja, Hans Wildiers, François P. Duhoux, Peter Vuylsteke, (unknown), Nancy Van Damme, Didier Verhoeven	4
9	Breast Cancer: global quality care optimizing care delivery with existing financial and personnel resources 2019 ·ESMO Open ·Didier Verhoeven, Claudia Allemani, Cary S. Kaufman, Robert E. Mansel, Sabine Siesling, Benjamin O. Anderson	18
10	First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study 2018 ·The Breast ·Angelo Di Leo, Guy Jérusalem, Roberto Torres, Didier Verhoeven, Kelly Pendergrass, Luca Malorni, (unknown), Miguel Martín	9
11	Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIES 2017 ·Breast Cancer Research and Treatment ·Maggie C.U. Cheang, Judith M. Bliss, Giuseppe Viale, Valerie Speirs, Carlo Palmieri, Abeer M. Shaaban, Per Eystein Lønning, James P. Morden, Núria Porta, Jacek Jassem, C J van de Velde, Birgitte Rasmussen, Didier Verhoeven, John M.S. Bartlett, R. Charles Coombes	2
12	Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO) 2015 ·Annals of Oncology ·Johan Vansteenkiste, Fabrice Barlési, Cornelius F. Waller, Jaafar Bennouna, Cesare Gridelli, Eray Goekkurt, Didier Verhoeven, Aleksandra Szczęsna, (unknown), Janusz Milanowski, Paul Germonpré, H. Léna, Djordje Atanackovic, Maciej Krzakowski, Christine Hicking, J. Sträub, Martin Picard, Wolfgang Schuette, Kenneth J. O’Byrne	64
13	Comparing duration of response and duration of clinical benefit between fulvestrant treatment groups in the CONFIRM trial: application of new methodology 2013 ·Breast Cancer Research and Treatment ·Sally Garnett, Miguel Martín, Guy Jérusalem, Luboš Petruželka, Roberto Torres, Igor Bondarenko, Р. Ш. Хасанов, Didier Verhoeven, José Luiz Pedrini, (unknown), Mikhail Lichinitser, Kelly Pendergrass, Justin P.O. Lindemann, Angelo Di Leo	17
14	Prospective Randomized Study Comparing Docetaxel, Estramustine, and Prednisone With Docetaxel and Prednisone in Metastatic Hormone-Refractory Prostate Cancer 2008 ·Journal of Clinical Oncology ·Jean‐Pascal Machiels, F Mazzeo, (unknown), Bertrand Filleul, Luc Marcelis, Brigitte Honhon, Lionel D’Hondt, (unknown), Vincent Verschaeve, Lionel Duck, Didier Verhoeven, (unknown), (unknown), (unknown), Bertrand Tombal, Joseph Kerger	62
15	Observational Aranesp® Survey to Investigate the Q3W Schedule (OASIS): a prospective observational study of treatment of chemotherapy-induced anaemia with every 3 weeks darbepoetin alfa 2008 ·Supportive Care in Cancer ·(unknown), (unknown), (unknown), F. Van Aelst, Koen Van Eygen, D. Galdermans, Didier Verhoeven, Marc Polus, (unknown), M. P. Derde, (unknown), Johan Vansteenkiste	6
16	Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study 1995 ·British Journal of Cancer ·P. Vermeulen, Didier Verhoeven, (unknown), Guy Hubens, G. Goovaerts, E. Van Marck, (unknown), A. Van Oosterom, (unknown)	67
17	Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas 1995 ·Annals of Oncology ·P. Vermeulen, Didier Verhoeven, Guy Hubens, E. Van Marck, G. Goovaerts, (unknown), E. A. de Bruijn, A.T. van Oosterom, Luc Dirix	83
18	Proliferation, basement membrane changes, metastasis and vascularization patterns in human breast cancer 1993 ·Pathology - Research and Practice ·Didier Verhoeven, Eric Van Marck	6
19	Ultrastructural Demonstration of Type IV Collagen Deposits in Periductal Elastosis in Breast Cancer 1993 ·Pathology - Research and Practice ·Didier Verhoeven, (unknown), N Buyssens, E. Van Marck, Jean‐Michel Foidart	5
20	Comparison of cell growth in different parts of breast cancers 1990 ·Histopathology ·Didier Verhoeven, (unknown), M.P. Derde, L. Kaufman, N Buyssens	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact